* agilon health inc AGL.N reported a quarterly adjusted
loss of
1 cent per share for the quarter ended in January, lower than
the same quarter last year, when the company reported EPS of 4
cents. The mean expectation of fifteen analysts for the quarter
was for a loss of one cent per share. Wall Street expected
results to range from -8 cents to 9 cents per share.
* Revenue rose 41.2% to $1.60 billion from a year ago;
analysts
expected $1.60 billion.
* agilon health inc's reported EPS for the quarter was a
loss of 1
cent.
* The company reported a quarterly loss of $6.06 million.
* agilon health inc shares had fallen by 20.8% this
quarter and
lost 61.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 137%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 12
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "hold"
Wall Street's median 12-month price target for agilon health inc
is $7.00
This summary was machine generated from LSEG data May 7 at 10:51
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.01 -0.01 Met
Dec. 31 2023 -0.30 -0.41 Missed
Sep. 30 2023 -0.06 -0.08 Missed
Jun. 30 2023 -0.03 -0.04 Missed